Recent News

• 02.12.2025 - Oppenheimer 35th Annual Healthcare Life Sciences Conference
• 02.07.2025 - Investor KOL Webinar – Addressing the High Unmet Need in Ataxia-Telangiectasia
• 02.07.2025 - Quince Therapeutics to Host Investor Webinar Today Focused on Addressing the High Unmet Need in Ataxia-Telangiectasia
• 02.05.2025 - Quince Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
• 02.04.2025 - Quince Therapeutics Receives Notice of Allowance Covering Innovative Method of Use for Lead Indication Ataxia-Telangiectasia
• 01.28.2025 - Quince Therapeutics to Host Investor Webinar on February 7, 2025 Focused on Addressing the High Unmet Need in Ataxia-Telangiectasia

Recent Filings